Cancer Immunology Research Fellowship (CIRF) Announced
Breakthrough Cancer Research in partnership with ‘5 For The Fight’ are delighted to announce the second round of the Cancer Immunology Research Fellowship (CIRF). Breakthrough and ‘5 For The Fight’ are committed to investing in research which harnesses the immune system in the fight against cancer. We are also committed to identifying and supporting future research leaders in translational cancer research.
The purpose of this fellowship is to fund two excellent cancer immunology-scientific research projects which shows the promise of impact for cancer patients. Dermot Costello, former Chairman of Qualtrics EMEA, was diagnosed with stage four colorectal cancer in 2014 and passed away in 2018 from this disease. He used the last months of his illness to kick-start ‘5 For The Fight’ in Ireland and Europe, a campaign that raises funds for cancer research to improve the outcome for patients. The first Fellowship in 2018 was named in his honour.
The CIRF 2021 will support two excellent early/mid-career-stage investigators to carry out independent research, each to the value of €300,000 over a three years period. The successful awardees of this cancer immunology fellowship will lead an independent research stream and identify and deliver ways to harness the immune system to eliminate cancer from the body. The translational research will focus on developing new immune-based treatments for poor prognosis cancers and advanced disease. More information on this exciting opportunity can be found on our website. www.breakthroughcancerresearch.ie/funding-information/